UK markets close in 5 hours 18 minutes

BLK Mar 2022 940.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
4.10000.0000 (0.00%)
As of 03:41PM EST. Market open.
Full screen
Previous close4.1000
Open5.2900
Bid0.0000
Ask0.0000
Strike940.00
Expiry date2022-03-18
Day's range4.1000 - 5.2900
Contract rangeN/A
Volume6
Open interestN/A
  • Bloomberg

    Fink’s Annual Letter Draws Fresh Backlash, This Time From Texas

    (Bloomberg) -- Texas is taking issue with BlackRock Inc. Chief Executive Officer Larry Fink’s latest annual letter, in which he sought to clarify the firm’s stance on fossil-fuel consumption and climate goals. Most Read from BloombergEarly Omicron Breakthroughs Show MRNA Vaccines’ WeaknessWhy Some Vaccinated People Resist Omicron and Others Don’tBiden Expects Russia to ‘Move In’ on Ukraine; Warns of SanctionsStocks Drop as Selloff Puts Nasdaq Into Correction: Markets WrapIs Covid Becoming Endemi

  • Bloomberg

    BlackRock, State Street Alums Map Plan to Disrupt Junk-Debt ETFs

    (Bloomberg) -- An ETF startup founded by former industry players at BlackRock Inc., State Street Corp. and JPMorgan Asset Management is stepping up efforts to disrupt the slow-moving world of junk debt.Most Read from BloombergEarly Omicron Breakthroughs Show MRNA Vaccines’ WeaknessStocks Drop as Selloff Puts Nasdaq Into Correction: Markets WrapMicrosoft Buys Scandal-Tainted Activision in Bet on MetaverseCovid-19 Infected Lions Prompt Variant Warning in South AfricaWhy Some Vaccinated People Resi

  • Bloomberg

    BlackRock Restarts Fundraising for Long-Term PE Strategy

    (Bloomberg) -- BlackRock Inc. is making a new push to raise money for its long-term private equity fund after initially struggling to attract investors.Most Read from BloombergEarly Omicron Breakthroughs Show MRNA Vaccines’ WeaknessStocks Drop as Selloff Puts Nasdaq Into Correction: Markets WrapMicrosoft Buys Scandal-Tainted Activision in Bet on MetaverseCovid-19 Infected Lions Prompt Variant Warning in South AfricaFourth Pfizer Dose Is Insufficient to Ward Off Omicron, Israeli Trial SuggestsThe